Bridgeway Capital Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Bridgeway Capital Management’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-64,000	Closed	-$47.7K	–	1275
2024 Q4	$47.7K	Sell	64,000 -55,000	-46%	-$54.8K	﹤0.01%	1160
2024 Q3	$145K	Hold	119,000	–	–	﹤0.01%	1115
2024 Q2	$246K	Sell	119,000 -25,000	-17%	-$58.9K	0.01%	1010
2024 Q1	$526K	Buy	+144,000	New	+$552K	0.01%	911

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Bridgeway Capital Management's OMGA Position: Q1 2025 in Review

Bridgeway Capital Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 64,000 shares — an estimated $47.7K sold.

Bridgeway Capital Management first reported a position in OMGA in Q1 2024 and held it in 4 quarters. The position peaked at $526K in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Bridgeway Capital Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Bridgeway Capital Management sold 64,000 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $47.7K.
Bridgeway Capital Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
Bridgeway Capital Management's Omega Therapeutics, Inc. Common Stock position peaked at $526K in Q1 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.